The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic features of the morphological subtypes in advanced pancreatic cancer.
 
Eugenia Flores-Figueroa
No Relationships to Disclose
 
Yuanchang Fang
No Relationships to Disclose
 
Maryam Monajemzadeh
No Relationships to Disclose
 
Ayah Elqaderi
No Relationships to Disclose
 
Tom Ouellette
No Relationships to Disclose
 
Amy Zhang
No Relationships to Disclose
 
Gun Ho Jang
No Relationships to Disclose
 
Karen Ng
No Relationships to Disclose
 
Milena Gallucci
No Relationships to Disclose
 
Zhen-Mei Liu
No Relationships to Disclose
 
Nikolina Radulovich
No Relationships to Disclose
 
Nhu An Pham
No Relationships to Disclose
 
Anna Dodd
No Relationships to Disclose
 
Julie Wilson
No Relationships to Disclose
 
Erica Tsang
Honoraria - AstraZeneca; Guardant Health; Incyte
Research Funding - Amgen; AstraZeneca; Roche/Genentech
 
Steven Gallinger
No Relationships to Disclose
 
Jennifer Knox
Honoraria - AstraZeneca; Incyte; Ipsen
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca; Incyte
 
Grainne O'Kane
Honoraria - AstraZeneca; Incyte; MSD Oncology; Roche; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca Canada; Incyte; Roche; Servier
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - MSD; Novartis; Takeda
 
Faiyaz Notta
No Relationships to Disclose
 
Robert Grant
Consulting or Advisory Role - AstraZeneca; Eisai; Guardant Health; Incyte; Ipsen; Knight Therapeutics
Research Funding - Pfizer